Hereditary Breast and Ovarian Cancer Syndrome
Showing 26 - 50 of >10,000
Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer Trial in Worldwide (Administration of
Recruiting
- Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer
- Administration of ceralasertib in combination with carboplatin
- +3 more
-
Duarte, California
- +26 more
Aug 17, 2022
Ovarian Cancer, Breast Cancer, Colorectal Cancer Trial in Houston (Genetic Testing and Counseling, Screening Form)
Recruiting
- Ovarian Cancer
- +2 more
- Genetic Testing and Counseling
- Screening Form
-
Houston, TexasM D Anderson Cancer Center
Dec 12, 2022
Tissue Expansion in Breast Reconstruction Without Drains
Completed
- Breast Cancer
- +2 more
- Insertion of Tissue Expander with Fluid Reservoir
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Oct 2, 2020
Factors Influencing Cascade Testing Among Hereditary
Recruiting
- Breast Carcinoma
- +8 more
- Interview
- +2 more
-
Birmingham, Alabama
- +1 more
Jun 22, 2022
Breast Cancer, Ovarian Cancer, Pancreatic Cancer Trial in United States (Standard Genetic Counseling, Educational Video)
Active, not recruiting
- Breast Cancer
- +3 more
- Standard Genetic Counseling
- Educational Video
-
Boston, Massachusetts
- +5 more
Jan 25, 2023
Cancer Trial in Philadelphia (Pre-Test Intervention, Standard of Care, Post-Test Intervention)
Recruiting
- Cancer
- Pre-Test Intervention
- +2 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center at University of Pennsylvania
Jan 30, 2023
Breast Cancer After Ovarian Cancer During and/or After Therapy:
Recruiting
- BRCA-Associated Breast Carcinoma
- Next-generation sequencing (NGS) assay TruSight Oncology 500 (TSO 500).
-
Rome, RM, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Mar 9, 2023
Young Patients With Early Breast Cancer
Not yet recruiting
- Breast Cancer Female
- operation
- (no location specified)
Sep 6, 2023
Endocrine Disruptors and Life STILe in Breast Cancer Development
Recruiting
- Breast Cancer
- +5 more
-
Roma, ItalyAlessandra Fabi
Feb 25, 2023
Gynecologic Cancer, Hereditary Cancer Syndrome Trial in New York (Chatbot)
Not yet recruiting
- Gynecologic Cancer
- Hereditary Cancer Syndrome
- Chatbot
-
New York, New YorkWeill Cornell Medicine
Dec 19, 2022
Breast Cancer Trial (Ovarian Function Suppression + Aromatase Inhibitor, Adjuvant Chemotherapy + Ovarian Function Suppression)
Not yet recruiting
- Breast Cancer
- Ovarian Function Suppression + Aromatase Inhibitor
- Adjuvant Chemotherapy + Ovarian Function Suppression
- (no location specified)
May 19, 2023
Lynch Syndrome, Endometrial Tumors, Ovarian Tumors Trial in Toronto (Questionnaire, Educational Material)
Active, not recruiting
- Lynch Syndrome
- +3 more
- Questionnaire, Educational Material
-
Toronto, Ontario, CanadaUniversity Health Network - Princess Margaret Hospital
May 16, 2022
Genes Contributing to Hereditary Ovarian Cancer in Women and
Completed
- Ovarian Cancer
-
Seattle, WashingtonUniversity of Washington
Feb 2, 2022
Hereditary Cancer Syndrome Trial (Mainstream Genetic Testing Model, Enhanced Standard of Care Model)
Not yet recruiting
- Hereditary Cancer Syndrome
- Mainstream Genetic Testing Model
- Enhanced Standard of Care Model
- (no location specified)
Dec 15, 2022
Patients With Breast Cancer and Pathogenic Variants of TP53
Completed
- Breast Cancer
- +3 more
- No intervention in this study
-
São Paulo, BrazilICESP
Aug 5, 2022
Prostate Cancer, Breast Cancer, Kidney Cancer Trial in Tampere (behavioral, drug, other)
Not yet recruiting
- Prostate Cancer
- +11 more
- Guided physical exercise
- +2 more
-
Tampere, Länsi-Suomi, FinlandTampere University Hospital
Apr 3, 2023
Li-Fraumeni Syndrome, TP53 Gene Mutation, Hereditary Cancer Syndrome Trial in Boston (Data and Specimen Collection)
Recruiting
- Li-Fraumeni Syndrome
- +4 more
- Data and Specimen Collection
-
Boston, Massachusetts
- +2 more
Jan 23, 2023
HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor Trial in Seattle
Active, not recruiting
- HER2-positive Breast Cancer
- +8 more
- pNGVL3-hICD vaccine
- +6 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Nov 1, 2022
Myofascial Pain Syndrome in Breast Cancer-related Lymphedema
Not yet recruiting
- Myofascial Pain Syndrome
- +5 more
- Diagnostic Criteria of Myofascial Pain Syndrome
- +6 more
-
İstanbul, Kadıköy, TurkeySultan 2. Abdulhamid Han Training and Research Hospital
Aug 22, 2023
Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian
Not yet recruiting
- Hormone-receptor-positive Breast Cancer
- +3 more
- Aromatase inhibitor
- +3 more
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Apr 5, 2023
Breast Cancer Female Trial (Vaginal Lactobacillus capsules)
Not yet recruiting
- Breast Cancer Female
- Vaginal Lactobacillus capsules
- (no location specified)
Aug 2, 2023
Advanced Fallopian Tube Carcinoma, Advanced Ovarian Carcinoma, Advanced Primary Peritoneal Carcinoma Trial in Portland (Wee1
Not yet recruiting
- Advanced Fallopian Tube Carcinoma
- +10 more
- Wee1 Inhibitor ZN-c3
-
Portland, OregonOHSU Knight Cancer Institute
Jan 25, 2023
Breast Cancer, Ovarian Tumor, Pain Trial in Albuquerque (Omega-3 fatty acid, Placebo, Paclitaxel)
Completed
- Breast Cancer
- +2 more
- Omega-3 fatty acid
- +2 more
-
Albuquerque, New Mexico
- +1 more
Oct 4, 2022
Breast Cancer, Estrogen Receptor Positive Tumor, HER2-negative Breast Cancer Trial in Seoul (Ovarian function suppression with
Not yet recruiting
- Breast Cancer
- +4 more
- Ovarian function suppression with endocrine treatments
-
Seoul, Korea, Korea, Republic ofGangnam Severance Hospital
Dec 18, 2022
Hereditary Cancer Syndrome Trial in Denver, Portland (Modified genetic counseling, Traditional genetic counseling)
Active, not recruiting
- Hereditary Cancer Syndrome
- Modified genetic counseling
- Traditional genetic counseling
-
Denver, Colorado
- +1 more
Jun 7, 2022